MX2018001548A - Procedimiento para la preparacion del compuesto n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) guanidina. - Google Patents
Procedimiento para la preparacion del compuesto n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) guanidina.Info
- Publication number
- MX2018001548A MX2018001548A MX2018001548A MX2018001548A MX2018001548A MX 2018001548 A MX2018001548 A MX 2018001548A MX 2018001548 A MX2018001548 A MX 2018001548A MX 2018001548 A MX2018001548 A MX 2018001548A MX 2018001548 A MX2018001548 A MX 2018001548A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- formula
- trifluoromethylphenyl
- dimethylphenyl
- guanidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/02—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/06—Purification or separation of guanidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación del compuesto N-(3,5-dimetilfenil)-N'-(2-trifluorometi lfenil) guanidina de fórmula (I) que comprende hacer reaccionar una sal de un compuesto de fórmula (II) o una mezcla de la sal del compuesto de fórmula (II) y un compuesto de fórmula (II) con un compuesto de fórmula (III), en presencia de un disolvente orgánico polar; a una forma sólida cristalina del compuesto de fórmula (I), en particular la forma sólida cristalina A; a una composición farmacéutica que las comprende; y a su uso como medicamento, en particular para el tratamiento de una condición mediada por proteínas celulares Rho-GTPasas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382424 | 2015-08-11 | ||
| ARP150102582A AR101498A1 (es) | 2015-08-11 | 2015-08-11 | Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a |
| PCT/EP2016/069033 WO2017025560A1 (en) | 2015-08-11 | 2016-08-10 | A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018001548A true MX2018001548A (es) | 2018-06-22 |
Family
ID=56799434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001548A MX2018001548A (es) | 2015-08-11 | 2016-08-10 | Procedimiento para la preparacion del compuesto n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) guanidina. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10343984B2 (es) |
| EP (1) | EP3334707B1 (es) |
| JP (1) | JP6748188B2 (es) |
| CN (1) | CN107922322B (es) |
| AR (1) | AR101498A1 (es) |
| BR (1) | BR112018002614B1 (es) |
| CA (1) | CA2994781A1 (es) |
| CY (1) | CY1122481T1 (es) |
| DK (1) | DK3334707T3 (es) |
| ES (1) | ES2756580T3 (es) |
| HK (1) | HK1256253A1 (es) |
| HR (1) | HRP20192301T1 (es) |
| HU (1) | HUE046959T2 (es) |
| LT (1) | LT3334707T (es) |
| MX (1) | MX2018001548A (es) |
| PL (1) | PL3334707T3 (es) |
| PT (1) | PT3334707T (es) |
| RS (1) | RS59759B1 (es) |
| RU (1) | RU2737430C2 (es) |
| SI (1) | SI3334707T1 (es) |
| WO (1) | WO2017025560A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN172842B (es) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
| WO1997045111A1 (en) * | 1996-05-24 | 1997-12-04 | Neurosearch A/S | Phenyl derivatives useful as blockers of chloride channels |
| US8283370B2 (en) * | 2008-10-03 | 2012-10-09 | The United States Of America As Represented By The Secretary Of The Army | Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use |
| CA2851205C (en) | 2011-10-11 | 2021-01-19 | Universidad Nacional De Quilmes | Phenyl-guanidine derivatives |
-
2015
- 2015-08-11 AR ARP150102582A patent/AR101498A1/es unknown
-
2016
- 2016-08-10 LT LTEP16756641.3T patent/LT3334707T/lt unknown
- 2016-08-10 RU RU2018107840A patent/RU2737430C2/ru active
- 2016-08-10 PL PL16756641T patent/PL3334707T3/pl unknown
- 2016-08-10 MX MX2018001548A patent/MX2018001548A/es unknown
- 2016-08-10 CA CA2994781A patent/CA2994781A1/en active Pending
- 2016-08-10 DK DK16756641.3T patent/DK3334707T3/da active
- 2016-08-10 WO PCT/EP2016/069033 patent/WO2017025560A1/en active Application Filing
- 2016-08-10 BR BR112018002614-0A patent/BR112018002614B1/pt active IP Right Grant
- 2016-08-10 CN CN201680045772.4A patent/CN107922322B/zh active Active
- 2016-08-10 EP EP16756641.3A patent/EP3334707B1/en active Active
- 2016-08-10 HU HUE16756641A patent/HUE046959T2/hu unknown
- 2016-08-10 JP JP2018506997A patent/JP6748188B2/ja active Active
- 2016-08-10 RS RS20191669A patent/RS59759B1/sr unknown
- 2016-08-10 PT PT167566413T patent/PT3334707T/pt unknown
- 2016-08-10 SI SI201630561T patent/SI3334707T1/sl unknown
- 2016-08-10 US US15/751,437 patent/US10343984B2/en active Active
- 2016-08-10 ES ES16756641T patent/ES2756580T3/es active Active
-
2018
- 2018-11-29 HK HK18115310.1A patent/HK1256253A1/zh unknown
-
2019
- 2019-12-20 HR HRP20192301TT patent/HRP20192301T1/hr unknown
- 2019-12-27 CY CY20191101359T patent/CY1122481T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2994781A1 (en) | 2017-02-16 |
| CN107922322B (zh) | 2023-11-03 |
| PL3334707T3 (pl) | 2020-05-18 |
| PT3334707T (pt) | 2020-01-14 |
| DK3334707T3 (da) | 2020-01-06 |
| SI3334707T1 (sl) | 2020-03-31 |
| ES2756580T3 (es) | 2020-04-27 |
| EP3334707A1 (en) | 2018-06-20 |
| AR101498A1 (es) | 2016-12-21 |
| BR112018002614A2 (es) | 2018-10-02 |
| CN107922322A (zh) | 2018-04-17 |
| RU2018107840A (ru) | 2019-09-12 |
| RS59759B1 (sr) | 2020-02-28 |
| LT3334707T (lt) | 2020-01-27 |
| HRP20192301T1 (hr) | 2020-03-20 |
| BR112018002614B1 (pt) | 2023-04-11 |
| WO2017025560A1 (en) | 2017-02-16 |
| EP3334707B1 (en) | 2019-10-09 |
| HK1256253A1 (zh) | 2019-09-20 |
| HUE046959T2 (hu) | 2020-04-28 |
| JP6748188B2 (ja) | 2020-08-26 |
| RU2737430C2 (ru) | 2020-11-30 |
| CY1122481T1 (el) | 2021-01-27 |
| US20180244608A1 (en) | 2018-08-30 |
| JP2018525393A (ja) | 2018-09-06 |
| US10343984B2 (en) | 2019-07-09 |
| RU2018107840A3 (es) | 2019-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| WO2017205536A3 (en) | Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer | |
| EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
| EP4071149A3 (en) | Heterocyclic compounds and uses thereof | |
| EA202090486A2 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201890123A1 (ru) | Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их | |
| WO2016105564A8 (en) | Quinazoline derivatives used to treat hiv | |
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| EA201792421A1 (ru) | Амидозамещенные производные циклогексана | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| EA201490864A1 (ru) | Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов | |
| EA201790246A1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
| EA201890771A1 (ru) | Соли и твердые формы монобактамного антибиотика | |
| TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| EA201892246A1 (ru) | Производные аминотиазола, полученные в качестве противовирусных средств | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| PH12019500822A1 (en) | Crystalline forms of eravacycline | |
| EA201691962A1 (ru) | Амидозамещенные азольные соединения в качестве ингибиторов tnks1 и/или tnks2 | |
| MX2016001095A (es) | Sales de dasatinib en forma cristalina. |